CCIA
Cherry Creek Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $484K | Buy |
10,447
+84
| +0.8% | +$3.89K | 0.23% | 65 |
|
|
2025
Q1 | $632K | Buy |
10,363
+97
| +0.9% | +$5.92K | 0.33% | 52 |
|
|
2024
Q4 | $581K | Buy |
10,266
+101
| +1% | +$5.71K | 0.29% | 52 |
|
|
2024
Q3 | $526K | Buy |
10,165
+183
| +2% | +$9.47K | 0.27% | 55 |
|
|
2024
Q2 | $415K | Sell |
9,982
-347
| -3% | -$14.4K | 0.22% | 69 |
|
|
2024
Q1 | $560K | Sell |
10,329
-14,872
| -59% | -$806K | 0.3% | 54 |
|
|
2023
Q4 | $1.29M | Sell |
25,201
-1,890
| -7% | -$97K | 0.79% | 30 |
|
|
2023
Q3 | $1.57M | Sell |
27,091
-1,183
| -4% | -$68.7K | 1.07% | 23 |
|
|
2023
Q2 | $1.81M | Buy |
28,274
+166
| +0.6% | +$10.6K | 1.22% | 21 |
|
|
2023
Q1 | $1.95M | Buy |
28,108
+210
| +0.8% | +$14.6K | 1.43% | 19 |
|
|
2022
Q4 | $2.01M | Buy |
27,898
+414
| +2% | +$29.8K | 1.56% | 18 |
|
|
2022
Q3 | $1.95M | Buy |
27,484
+189
| +0.7% | +$13.4K | 1.62% | 16 |
|
|
2022
Q2 | $2.1M | Buy |
27,295
+137
| +0.5% | +$10.6K | 1.7% | 17 |
|
|
2022
Q1 | $1.98M | Buy |
27,158
+315
| +1% | +$23K | 1.31% | 22 |
|
|
2021
Q4 | $1.67M | Buy |
26,843
+557
| +2% | +$34.7K | 1.04% | 29 |
|
|
2021
Q3 | $1.56M | Sell |
26,286
-405
| -2% | -$24K | 1.04% | 31 |
|
|
2021
Q2 | $1.78M | Buy |
+26,691
| New | +$1.78M | 1.17% | 26 |
|